1. Home
  2. ORMP vs CODA Comparison

ORMP vs CODA Comparison

Compare ORMP & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • CODA
  • Stock Information
  • Founded
  • ORMP 2002
  • CODA 1994
  • Country
  • ORMP United States
  • CODA United States
  • Employees
  • ORMP N/A
  • CODA N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • ORMP Health Care
  • CODA Industrials
  • Exchange
  • ORMP Nasdaq
  • CODA Nasdaq
  • Market Cap
  • ORMP 90.7M
  • CODA 92.5M
  • IPO Year
  • ORMP N/A
  • CODA N/A
  • Fundamental
  • Price
  • ORMP $2.40
  • CODA $7.89
  • Analyst Decision
  • ORMP Hold
  • CODA Strong Buy
  • Analyst Count
  • ORMP 1
  • CODA 1
  • Target Price
  • ORMP N/A
  • CODA $11.00
  • AVG Volume (30 Days)
  • ORMP 493.3K
  • CODA 30.1K
  • Earning Date
  • ORMP 03-05-2025
  • CODA 03-17-2025
  • Dividend Yield
  • ORMP N/A
  • CODA N/A
  • EPS Growth
  • ORMP N/A
  • CODA 14.29
  • EPS
  • ORMP 0.11
  • CODA 0.32
  • Revenue
  • ORMP N/A
  • CODA $20,316,161.00
  • Revenue This Year
  • ORMP N/A
  • CODA $31.72
  • Revenue Next Year
  • ORMP N/A
  • CODA $12.23
  • P/E Ratio
  • ORMP $21.93
  • CODA $24.66
  • Revenue Growth
  • ORMP N/A
  • CODA 4.98
  • 52 Week Low
  • ORMP $2.00
  • CODA $5.48
  • 52 Week High
  • ORMP $3.67
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 55.14
  • CODA 44.05
  • Support Level
  • ORMP $2.16
  • CODA $7.75
  • Resistance Level
  • ORMP $3.09
  • CODA $8.58
  • Average True Range (ATR)
  • ORMP 0.15
  • CODA 0.29
  • MACD
  • ORMP 0.03
  • CODA 0.00
  • Stochastic Oscillator
  • ORMP 28.87
  • CODA 16.87

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: